Patent Invalidation in Mexico City.

A patent invalidation Mexico City strategy has to begin with a structural fact that surprises most foreign litigants: in Mexico a patent is not knocked out by a civil court, but by the patent office itself. Mexico City is the seat of the Instituto Mexicano de la Propiedad Industrial (IMPI), the administrative authority that grants patents and, at first instance, decides whether they should be declared void. It is also home to the Specialised Intellectual Property Chamber of the Tribunal Federal de Justicia Administrativa (TFJA), which reviews IMPI’s rulings before matters reach the Collegiate Circuit Courts on amparo. PerspireIP builds invalidity-grade prior-art searches for the accused parties, generic and biosimilar entrants, and litigation counsel who have to attack a Mexican patent through this administrative chain.

Why patent invalidation Mexico City runs through IMPI, not a court

Mexico takes an administrative path to patent validity that sets it apart from the United States and most of Europe. There is no separate civil revocation suit and no invalidity counterclaim heard by a district judge. Instead, a party asks IMPI to issue a declaración administrativa de nulidad — an administrative declaration of nullity — and IMPI, the same body that granted the patent after substantive examination, decides whether it should stand.

The same authority also handles infringement. A patentee brings an administrative infringement action before IMPI, and an accused party can respond by filing a nullity action attacking the asserted patent. Both live inside the same administrative forum in Mexico City, which is why the decisive contest so often becomes the validity fight rather than the infringement read.

That structure raises the stakes on the prior art. A nullity declaration is retroactive: under the Federal Law for the Protection of Industrial Property, its effects reach back to the filing date of the application, wiping the patent from inception rather than merely from the ruling forward. Because everything turns on what IMPI’s examiners and the reviewing chamber accept as anticipating or obviating art, the invalidity search is not a supporting exhibit — it is the case.

• IMPI — grants patents and decides administrative nullity and infringement at first instance
• Specialised IP Chamber, TFJA — reviews IMPI’s rulings through an annulment (nulidad) trial
• Collegiate Circuit Courts — hear the constitutional amparo that follows the TFJA judgment
• COFEPRIS — the health regulator linked to IMPI for pharmaceutical patent matters

The 2020 LFPPI reset the nullity rules

The governing statute is recent. The Federal Law for the Protection of Industrial Property (Ley Federal de Protección a la Propiedad Industrial, or LFPPI) came into force on 5 November 2020, replacing the old Industrial Property Law that had governed since 1991. The reform modernised the whole framework, and it reshaped how nullity is grounded, pleaded and timed.

The grounds for nullity are consolidated in the LFPPI. A Mexican patent can be declared void where it was granted contrary to the law in force at the time of grant; where the invention did not meet the patentability requirements, chiefly novelty or inventive step; where the specification did not disclose the invention sufficiently for a skilled person to carry it out; or where the grant was obtained in error, oversight or bad faith. Novelty and inventive step dominate the contested cases, which is exactly where a dated prior-art record decides the outcome.

The LFPPI also sharpened the pharmaceutical picture. It codified a Bolar-type exception, allowing experimental use and regulatory studies before a patent expires, and it reinforced the linkage system that ties IMPI’s patent register to marketing approvals granted by COFEPRIS, the federal health-risk commission. For generic and biosimilar entrants, a patent invalidation Mexico City action often runs in parallel with a linkage and regulatory clearance strategy, so the search has to be timed to both tracks.

Because the statute is only a few years old, its provisions are still being interpreted by IMPI and tested before the TFJA and the courts. That makes the underlying prior art even more important: where the procedural contours are still settling, a clean anticipation or a well-documented obviousness combination gives the reviewing bodies the firmest ground to rule on, and it is far less exposed to shifting procedural argument than a case built on formalities.

Review of an IMPI nullity ruling: the TFJA Specialised IP Chamber

An IMPI nullity decision is not the last word. A party that disagrees can challenge it before the Specialised Intellectual Property Chamber (Sala Especializada en Materia de Propiedad Intelectual) of the Tribunal Federal de Justicia Administrativa — the Federal Court of Administrative Justice — by filing an annulment trial (juicio de nulidad). This specialised chamber sits in Mexico City and hears virtually every contested Mexican patent, trademark and design matter, giving the capital an unusually concentrated body of IP case law.

The chamber conducts a genuine merits review of the administrative record. It can confirm IMPI’s ruling, annul it, or order IMPI to issue a fresh decision. Because the TFJA re-examines how the prior art was read against the claims, an invalidity file has to be built to survive a second, more demanding reading — not just to persuade an examiner at first instance.

Standing matters throughout. The TFJA and IMPI have held that a challenger must show real and direct harm to attack a patent; simply operating in the same market is not enough. A party without standing may still ask IMPI to open a nullity procedure of its own motion. Either way, the strength of the prior art is what turns a bare request into a declaration, so the search and its dating do the heavy lifting from the very first filing.

The final layer: amparo before the Collegiate Circuit Courts

After the TFJA rules, the losing party can seek amparo, Mexico’s constitutional remedy, before the Collegiate Circuit Courts (Tribunales Colegiados de Circuito) in administrative matters. This is where a patent validity dispute finally leaves the specialised IP track and enters the federal judiciary, tested for constitutional and legality violations rather than re-tried on the technical merits.

The practical effect is a three-tier chain: IMPI decides, the TFJA Specialised IP Chamber reviews, and the Collegiate Circuit Courts hear the amparo — with almost every stage seated in Mexico City. A patent can be litigated for years across these layers, and the same prior-art record is carried from IMPI’s file all the way to the amparo. A reference that was weak or poorly dated at first instance rarely improves on review, which is why the invalidity search has to be built to appellate standard from day one.

For foreign litigants used to a single trial court, this multi-forum path changes the economics. The cost of a patent invalidation Mexico City campaign is spread across administrative and judicial stages, and the leverage created by a decisive early prior-art hit — a clean anticipation or a well-charted obviousness combination — can shorten the whole chain or drive an early settlement.

Where Mexico City’s patent disputes come from

Mexico City concentrates the country’s IP caseload because it concentrates its economy and its institutions. As the seat of both IMPI and the TFJA Specialised IP Chamber, the capital sees nearly all Mexican patent disputes filed and reviewed within its jurisdiction, whatever the industry or the location of the parties.

Pharmaceuticals drive the highest-stakes fights. Mexico is a major market for originator and generic medicines, and the IMPI–COFEPRIS linkage system turns patent validity into the gateway for generic and biosimilar entry. These disputes usually turn on formulation, polymorph, salt and second-medical-use claims, where the decisive art is a journal paper, a chemistry abstract or an older patent family rather than a headline patent.

Consumer goods, telecoms and finance round out the docket. Fast-moving consumer products generate design and utility disputes; telecoms and electronics matters turn on standards, datasheets and prior patent families; and the capital’s large financial and fintech sector produces software-adjacent and payments-technology claims. Each cluster invalidates differently, so the search has to be built for the technology and the forum, not run from a template.

The concentration also shapes strategy. Because IMPI, the TFJA Specialised IP Chamber and the reviewing Collegiate Circuit Courts all sit in Mexico City, a challenger can build a single record and follow it through every layer without changing forum or venue. That continuity rewards early investment in the prior art: a reference that anticipates a claim at IMPI is the same reference the TFJA weighs on annulment and the same one that anchors the amparo, so the quality of the initial search compounds across the whole dispute.

Grounds and evidence that decide a Mexican nullity action

Under the LFPPI a Mexican patent falls on a defined set of grounds, and in contested cases two of them do most of the work. The first is lack of novelty: a single prior disclosure, anywhere in the world and before the priority date, that shows every element of the claim. The second is lack of inventive step: a combination of disclosures that would have been obvious to a person skilled in the art. Insufficiency of disclosure and grant obtained in error, oversight or bad faith complete the list, and they surface most often in pharmaceutical and hard-science matters where the specification is dense.

What IMPI and the TFJA will accept as proof is where cases are won or lost. A prior-art reference only bites if it was genuinely available to the public before the governing priority date, and if that availability can be shown with evidence rather than asserted. Publication dates, indexing records, library stamps, conference proceedings and archived web captures all become exhibits, and a Spanish translation or certified copy is frequently required for a foreign-language reference to be weighed at all.

That evidentiary discipline is why a template search fails in Mexico. A reference list without dating proof, or a chart that does not map each claim element to a specific passage, gives IMPI nothing to declare on and gives the TFJA nothing to review. The strongest nullity files pair a rigorous search with a documented chain of public availability, so the same record holds up as it climbs from IMPI to the Specialised IP Chamber and, if needed, to the amparo.

How PerspireIP builds a patent invalidation Mexico City case

Every engagement follows the same disciplined path. We map the asserted claims element by element, fix the priority date that actually governs each one, and search against that date rather than the filing date printed on the cover. For pharma and biotech subject-matter we run patent and deep non-patent-literature retrieval in parallel; for consumer, telecoms and electronics matters we add standards, datasheets and product literature. Then we build claim charts that IMPI and the TFJA can follow line by line.

• Claim charting mapped to novelty and inventive step under the LFPPI
• Parallel patent and non-patent-literature searching tuned to pharma, consumer, telecoms or fintech claims
• Public-availability dating evidenced for every reference in Spanish and English
• Prior art sized to your forum — an IMPI nullity action, a TFJA annulment trial, or an amparo record
• A written invalidity analysis and reference packages ready for IMPI’s examiners and the Specialised IP Chamber

The other half of the work is proof of date. A reference only counts if it was genuinely public before the priority date a claim relies on, so we treat public-availability dating as evidence — capturing print dates, archive timestamps, indexing dates and library records that IMPI or the TFJA can accept without argument, and that survive the amparo review.

We work alongside your Mexican patent attorneys and agentes as a specialist search partner, deliver to IMPI and TFJA deadlines, and keep every engagement confidential. Whether you are a manufacturer defending an IMPI infringement action, a generic or biosimilar entrant clearing a linkage path with COFEPRIS in view, or litigation counsel coordinating a nullity action with its TFJA and amparo review, we scale to fit. Send us the patent number and your key dates, and we will scope a patent invalidation Mexico City project within one business day.

IP Landscape & Resources in Mexico City

Key intellectual-property authorities and venues relevant to Mexico City:

• Instituto Mexicano de la Propiedad Industrial (IMPI) — the Mexican Institute of Industrial Property; it grants patents after substantive examination and decides administrative nullity and infringement actions at first instance
• Tribunal Federal de Justicia Administrativa (TFJA) — the Federal Court of Administrative Justice; its Specialised Intellectual Property Chamber (Sala Especializada en Materia de Propiedad Intelectual) reviews IMPI's rulings through an annulment trial
• Federal Law for the Protection of Industrial Property (LFPPI) — the statute in force since 5 November 2020 that sets the grounds and procedure for patent nullity, the Bolar exception and the COFEPRIS linkage, published by the Camara de Diputados
• COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios) — the federal health-risk commission whose marketing approvals are linked to IMPI's patent register, central to generic and biosimilar entry

Request a Patent Invalidation Search in Mexico City

Explore related PerspireIP services: Patent Invalidation · Prior Art Litigation Search · Patent Infringement Analysis.

Frequently Asked Questions